GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Median Technologies (XPAR:ALMDT) » Definitions » Research & Development

Median Technologies (XPAR:ALMDT) Research & Development : €0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Median Technologies Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Median Technologies's Research & Development for the six months ended in Dec. 2024 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Median Technologies Research & Development Historical Data

The historical data trend for Median Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Median Technologies Research & Development Chart

Median Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Median Technologies Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Median Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Median Technologies  (XPAR:ALMDT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Median Technologies Research & Development Related Terms

Thank you for viewing the detailed overview of Median Technologies's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Median Technologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Median Technologies (XPAR:ALMDT) » Definitions » Research & Development
Comparable Companies
XPAR:ALCAR XPAR:AFME XPAR:ALNOV XPAR:ALBIO XPAR:ALDMS XPAR:ALIKO XPAR:ALIMP XPAR:ALBLU XPAR:ALTHE XPAR:ALSGD ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
4ZG:Germany
Address
1800 Route Des Cretes, Les Deux Arcs B, Valbonne, FRA, 06560
Website
https://www.mediantechnologies.com
Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The firm intends to target the oncology clinical trials market and the cancer patient care market. It developed software-based tools that are integrated into a clinical application portfolio called Lesion Management Solutions. The company has two platforms, iSee for imaging services in clinical trials and iBiopsy for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer and other chronic diseases. Its geographical segments are France, the USA/Canada, the United Kingdom, China, and Other countries.

Median Technologies Headlines

No Headlines